Occidental Petroleum, ExxonMobil, Chevron Fall In Pre-Market As Oil Prices Plunge Amid Trump's US-Iran Nuclear Deal Comments
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up
Ethereum Pushes Towards $3000 Breakout Amid Institutional Surge
Expert Outlook: AbbVie Through The Eyes Of 10 Analysts
AbbVie Analyst Ratings
Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of 'Compound Interest'
Trump Unveils 'Historic And Transformative' $600 Billion Saudi Deal, Predicts Markets Will 'Go a Lot Higher'
A Look Into AbbVie Inc's Price Over Earnings
13 Analysts Have This To Say About Johnson & Johnson
World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know
Peering Into Johnson & Johnson's Recent Short Interest
Johnson & Johnson Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $169 to $153.
What Does the Market Think About AbbVie?
Exxon Mobil Analyst Ratings
Johnson & Johnson Analyst Ratings
Chevron Analyst Ratings
AST SpaceMobile Sets $75 Million Target For 2025 As CFO Andrew Johnson Says 'Revenue Is Ramping On Plan' Amid Surging Demand For Direct-To-Device Satellite Connectivity
U.S. stock market close: The Nasdaq surged over 4%, Chinese concept stocks performed even stronger, and the Golden Dragon Index outperformed the Large Cap.
① High-level economic and trade talks between China and the U.S. exceeded expectations, boosting U.S. stocks; ② Both the S&P and Nasdaq hit new closing highs since March 3; ③ NVIDIA rose over 5%, with its Market Cap returning to above 3 trillion; ④ Trump: Will investigate pharmaceutical companies if necessary.
7 Communication Services Stocks Whale Activity In Today's Session